HIV: Management of Concomitant Conditions

Volume 3, Issue 2.

In this podcast Dr. Alysse Wurcel discusses important drug-drug interactions that may impact the treatment of ischemic heart disease in people living with HIV, medication interactions that could influence the treatment of common comorbid diseases, and potential drug-drug interactions between antiretroviral agents and common over-the-counter medications.

Take our post-test to claim CME credits.

To read a companion newsletter click here.

Using Real World Data to Individualize HCV Management

Volume 5, Issue 8.

In this podcast, Andrew J. Muir, MD from Duke University School of Medicine discusses the real-world data to support a sofosbuvir-ledipasvir treatment duration of 8 weeks versus 12 weeks, summarizes the current hepatitis C treatment options for patients with advanced kidney disease, and describes the risks and benefits of hepatitis C therapies in HIV-HCV coinfected patients.

Take our post-test to claim CME credits:
Physician post-test
Nurse post-test

To read a companion newsletter click here.

New Directions in CFTR Modification

Volume 7, Issue 8.

In this podcast Dr. George Solomon discusses new directions in CFTR modification in the context of case studies.

Take our post-test to claim CME credits:
Physician post-test
Nurse post-test

To read a companion newsletter click here.